Randomised, phase 1, dose-finding study of MEDI4166, a PCSK9 antibody and GLP-1 analogue fusion molecule, in overweight or obese patients with type 2 diabetes mellitus
Titel:
Randomised, phase 1, dose-finding study of MEDI4166, a PCSK9 antibody and GLP-1 analogue fusion molecule, in overweight or obese patients with type 2 diabetes mellitus
Auteur:
Jain, Meena Carlson, Glenn Cook, William Morrow, Linda Petrone, Marcella White, Nicholas E. Wang, Tao Naylor, Jacqueline Ambery, Philip Lee, Charles Hirshberg, Boaz